Here's why they chose AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), and Pfizer (NYSE: PFE). Rest easy with this biotech giant Prosper Junior Bakiny (Amgen): The COVID-19 pandemic, geopolitical tensions, inflation. Its COVID-19 revenue may not be as significant in a few years as it is right now, but the company is taking advantage of the strong profits and cash flow it is generating from that to make its business better in the long run.